AL590483.1 was included in a 15-lncRNA signature to predict the OS of patients with CRC, and it may function as a ceRNA to regulate the p53 and Wnt signaling pathways and thus regulate tumor progression (23). This evidence concerns the gene TP53 and neoplasm.